Manuscripts
Showing 1556 manuscripts.
Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania
Citation
Meghan K. Mayhood, Isaac A. Afwamba, Christopher O. Odhiambo, Epimack Ndanu, Nathan Thielman, Anne B. Morrissey, John F. Shao, Brian Wells Pence, John A. Crump. Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania. Journal of Clinical Microbiology. 2008. 46: 3946-51.Year
2008
Journal
Journal of Clinical Microbiology
Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide
Citation
Vincent C. Marconi, Sebastian Bonhoeffer, Roger Paredes, Jing Lu, Rebecca Hoh, Jeffrey N. Martin, Steven G. Deeks, Daniel R. Kuritzkes. Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide. Journal of Acquired Immune Deficiency Syndromes. 2008. 48: 572-6.Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men
Citation
David M. Butler, Davey M. Smith, Edward R. Cachay, George K. Hightower, Charles Nugent, Douglas D. Richman, Susan J. Little. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS. 2008. 22: 1667-71.Year
2008
Journal
AIDS
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects
Citation
R. Pat Bucy, Homer L. Twigg, Michael D. Weiden, Fred T. Valentine, Carol T Schnizlein Bick, Roland Bassett, Lu (Summer) Zheng, L. Joseph Wheat, Richard B. Day, Helen C. Rominger-Grubbs, Ronald G. Collman, Lawrence Fox, Barbara Brizz, Joan Dragavon, Robert W. Coombs. Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. Journal of Infectious Diseases. 2008. 197: 109-116.Year
2008
Journal
Journal of Infectious Diseases
Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in Sub-Saharan Africa.
Citation
Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in Sub-Saharan Africa.. Pediatric Infectious Disease Journal. 2008. 27: 251-6. PMID: 18277935Year
2008
Journal
Pediatric Infectious Disease Journal
Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.
Citation
Katherine Tassiopoulos, Paige L. Williams, George Seage, Marilyn Jean Crain, James M. Oleske, John J. Farley. Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.. Journal of Acquired Immune Deficiency Syndromes. 2008. 47: 607-14. PMID: 18209684Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Long-term effects of highly active antiretroviral therapy on CD4 evolution among children and adolescents infected with HIV-1: five years and counting.
Citation
Kunjal Patel, Miguel A. Hernan, Paige L. Williams, John D. Seeger, Kenneth McIntosh, Russell B. Van Dyke, George Seage. Long-term effects of highly active antiretroviral therapy on CD4 evolution among children and adolescents infected with HIV-1: five years and counting.. Clinical Infectious Diseases. 2008. 46: 1751-60. PMID: 18426371Year
2008
Journal
Clinical Infectious Diseases
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Citation
Kunjal Patel, Miguel A. Hernan, Paige L. Williams, John D. Seeger, Kenneth McIntosh, Russell B. Van Dyke, George Seage. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.. Clinical Infectious Diseases. 2008. 46: 507 - 515. PMID: 18199042Year
2008
Journal
Clinical Infectious Diseases
Pharmacokinetics of high-dose lopinavir/ritonavir with and without saquinavir or non-nucleoside reverse transcriptase inhibitors in HIV infected pediatric and adolescent patients previously treated with protease inhibitors ¿ study PACTG P1038.
Citation
Brian Robbins, Edmund Capparelli, Ellen Gould Chadwick, Ram Yogev, Leslie Serchuck, Carol J. Worrell, Carmelita Alvero, Terence Fenton, Barbara E. Heckman, Stephen Ira Pelton, Grace M. Aldrovandi, William Borkowsky, John H. Rodman, Peter Havens. Pharmacokinetics of high-dose lopinavir/ritonavir with and without saquinavir or non-nucleoside reverse transcriptase inhibitors in HIV infected pediatric and adolescent patients previously treated with protease inhibitors ¿ study PACTG P1038.. Antimicrobial Agents and Chemotherapy. 2008. 52: 3276-83. PMID: 18625762Year
2008
Journal
Antimicrobial Agents and Chemotherapy
Study
P1038
Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents.
Citation
Juan Carlos Salazar, Pedro E. Cahn, Ram Yogev, Marinella Della Negra, Guido Castelli-Gattinara, Claudia Fortuny, Patricia M. Flynn, Carlo Giaquinto, Ping Ruan, Elizabeth (Betsy) Smith, Jaromir Mikl, Hernan Valdez, Ante Jelaska. Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents.. AIDS. 2008. 22: 1789-98. PMID: 18753862Year
2008
Journal
AIDS
Study
P1051